Beta-3 adrenergic receptor

From HandWiki - Reading time: 5 min

Short description: Mammalian protein found in Homo sapiens


A representation of the 3D structure of the protein myoglobin showing turquoise α-helices.
Generic protein structure example

The beta-3 adrenergic receptor3-adrenoceptor), also known as ADRB3, is a beta-adrenergic receptor, and also denotes the human gene encoding it.[1]

Function

Actions of the β3 receptor include

It is located mainly in adipose tissue and is involved in the regulation of lipolysis and thermogenesis. Some β3 agonists have demonstrated antistress effects in animal studies, suggesting it also has a role in the central nervous system (CNS). β3 receptors are found in the gallbladder, urinary bladder, and in brown adipose tissue. Their role in gallbladder physiology is unknown, but they are thought to play a role in lipolysis and thermogenesis in brown fat. In the urinary bladder it is thought to cause relaxation of the bladder and prevention of urination.[4]

Mechanism of action

Beta adrenergic receptors are involved in the epinephrine- and norepinephrine-induced activation of adenylate cyclase through the action of the G proteins of the type Gs.[1]

Ligands

Agonists

Antagonists

Interactions

Beta-3 adrenergic receptor has been shown to interact with Src.[17]

See also

References

  1. 1.0 1.1 "Entrez Gene: ADRB3 adrenergic, beta-3-, receptor". https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=155. 
  2. "Combined effects of oleoyl-estrone and a β3-adrenergic agonist (CL316,243) on lipid stores of diet-induced overweight male Wistar rats". Life Sciences 77 (16): 2051–8. September 2005. doi:10.1016/j.lfs.2005.04.008. PMID 15935402. https://zenodo.org/record/889563. 
  3. Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4.  Page 163
  4. "Recent Developments in the Design of Orally Bioavailable β3-Adrenergic Receptor Agonists". Current Medicinal Chemistry 13 (1): 25–37. 2006. doi:10.2174/092986706775198006. PMID 16457637. 
  5. "Behavioral effects of the β3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?". European Journal of Pharmacology 573 (1–3): 139–47. November 2007. doi:10.1016/j.ejphar.2007.06.048. PMID 17669397. 
  6. "Confirmation of antidepressant potential of the selective β3 adrenoceptor agonist amibegron in an animal model of depression". Pharmacology Biochemistry and Behavior 89 (4): 623–6. June 2008. doi:10.1016/j.pbb.2008.02.020. PMID 18358519. 
  7. "BRL37344 stimulates GLUT4 translocation and glucose uptake in skeletal muscle via β2-adrenoceptors without causing classical receptor desensitization". American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 316 (5): R666–R677. May 2019. doi:10.1152/ajpregu.00285.2018. PMID 30892909. 
  8. "The effects of beta(3)-adrenoceptor agonist CL-316,243 on adiponectin, adiponectin receptors and tumor necrosis factor-alpha expressions in adipose tissues of obese diabetic KKAy mice". European Journal of Pharmacology 584 (1): 202–6. 2008. doi:10.1016/j.ejphar.2008.01.028. PMID 18304529. 
  9. 9.0 9.1 9.2 "Potent and selective human beta(3)-adrenergic receptor antagonists.". The Journal of Pharmacology and Experimental Therapeutics 290 (2): 649–55. Aug 1999. PMID 10411574. 
  10. "Effect of a 28-d treatment with L-796568, a novel β3-adrenergic receptor agonist, on energy expenditure and body composition in obese men". The American Journal of Clinical Nutrition 76 (4): 780–8. 2002. doi:10.1093/ajcn/76.4.780. PMID 12324291. 
  11. "Mirabegron for the treatment of overactive bladder". Drugs of Today 48 (1): 25–32. 2012. doi:10.1358/dot.2012.48.1.1738056. PMID 22384458. 
  12. "Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart". J Am Coll Cardiol 53 (17): 1532–8. 2009. doi:10.1016/j.jacc.2008.11.057. PMID 19389564. 
  13. "GW427353 (solabegron), a novel, selective beta3-adrenergic receptor agonist, evokes bladder relaxation and increases micturition reflex threshold in the dog". The Journal of Pharmacology and Experimental Therapeutics 323 (1): 202–9. October 2007. doi:10.1124/jpet.107.125757. PMID 17626794. 
  14. "Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder.". Journal of Medicinal Chemistry 59 (2): 609–23. January 2016. doi:10.1021/acs.jmedchem.5b01372. PMID 26709102. 
  15. "Functional studies of the first selective β3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes". Mol. Pharmacol. 49 (1): 7–14. 1996. PMID 8569714. 
  16. "Role of α1- and β3-adrenoceptors in the modulation by SR59230A of the effects of MDMA on body temperature in the mouse". British Journal of Pharmacology 158 (1): 259–66. April 2009. doi:10.1111/j.1476-5381.2009.00186.x. PMID 19422394. 
  17. "Direct binding of activated c-Src to the beta 3-adrenergic receptor is required for MAP kinase activation". J. Biol. Chem. 275 (49): 38131–4. 2000. doi:10.1074/jbc.C000592200. PMID 11013230. 

Further reading

External links




Licensed under CC BY-SA 3.0 | Source: https://handwiki.org/wiki/Biology:Beta-3_adrenergic_receptor
4 views | Status: cached on July 31 2024 21:48:52
↧ Download this article as ZWI file
Encyclosphere.org EncycloReader is supported by the EncyclosphereKSF